Neurodegenerative diseases diagnosis often happens too late when the patient already shows symptoms.
+10 million people in the world suffer of Parkinson’s disease and this number is predicted to redouble by 2030.
EXOPROBES is developing a unique early diagnosis platform for Neurodegenerative disease. Simple and Specific Blood & Saliva based liquid biopsy.
Exoprobes’ test platform performs early diagnostic of Neurodegenerative disease before symptoms arise increasing patient’s quality life allowing specific and timely treatment, saving time, money and lives.
more
